Pfizer Q2 Results: Stock up 5% after net profit jumps 66% on ₹132 crore one-time gain

Pfizer India reported a strong Q2 performance, with net profit surging 66% year-on-year to ₹313 crore. This jump was largely driven by a one-time gain of ₹132 crore. Revenue also grew by 13.2% to ₹727 crore, while EBITDA increased by 14.4% to ₹262 crore. The company maintained its operating margin at 36%.
For investors, the results highlight a solid operational recovery, with both revenue and earnings expanding. However, the significant boost from the one-time gain means the underlying business growth is slightly lower than the headline numbers suggest. This makes the flat margin a key point to monitor for future quarters.
Going forward, investors should watch the company's ability to sustain this growth without relying on one-off gains. The focus will be on whether the company can maintain its margins and continue expanding its revenue base in the coming quarters.
Excerpt from CNBC-TV18
Published On Nov 3, 2026 | 15:25 IST Last Updated On Nov 3, 2026 | 15:33 IST Pfizer India posted a sharp profit surge driven by a substantial one-time windfall, alongside double-digit revenue growth and steady operational margins. Share prices rallied following the earnings announcement. Discover how core…Read the original at CNBC-TV18
Affected stocks
Bullish1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Pfizer (PFIZER).
- Category: Results.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update for Pfizer worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.











